Litcius/Paper detail

Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients

Toon Ieven, Thomas Van Weyenbergh, Martijn Vandebotermet, David Devolder, Christine Breynaert, Rik Schrijvers

2021The Journal of Allergy and Clinical Immunology In Practice19 citationsDOIOpen Access PDF

Topics & Concepts

MedicineTolerabilityPolyethylene glycolCoronavirus disease 2019 (COVID-19)Polysorbate2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)VirologyPharmacologyInternal medicineAdverse effectInfectious disease (medical specialty)Pulmonary surfactantDiseaseOutbreakEngineeringChemical engineeringThermodynamicsPhysicsDrug-Induced Adverse ReactionsInhalation and Respiratory Drug DeliveryContact Dermatitis and Allergies
Tolerability of polysorbate 80–containing COVID-19 vaccines in confirmed polyethylene glycol–allergic patients | Litcius